Evidence map›Paper›PMID 24089413›Full record

ArticleAmerican journal of physiology. Renal physiology2013

A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.

Elaine M Worcester, Andrew P Evan, Fredric L Coe, James E Lingeman, Amy Krambeck, Andre Sommers, Carrie L Phillips, Dawn Milliner

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Urine Oxalate Excretion and CKD Stage in Patients With Primary Hyperoxaluria Type 1.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  5. Oxalate homeostasis.Nature reviews. Nephrology · 2023
    Review
  6. Article
  7. End Points for Clinical Trials in Hyperoxaluria: Case Study of Patient-Focused Drug Development in a Rare Disease.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  12. Article
  13. Article
  14. Journal of endourology · 2020
    Article
  15. Article
  16. Dietary oxalate and kidney stone formation.American journal of physiology. Renal physiology · 2019
    Review
  17. Review
  18. SGLT2 Inhibitors and Mechanisms of Hypertension.Current cardiology reports · 2018 · on this map
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elaine M WorcesterNephrology Section, MC5100, Univ. of Chicago, School of Medicine, 5841 South Maryland Ave., Chicago, IL 60637. eworcest@uchicago.edu.
Andrew P Evan
Fredric L Coe
James E Lingeman
Amy Krambeck
Andre Sommers
Carrie L Phillips
Dawn Milliner

Funding

SWL AND RENAL INJURY AND STONE COMMINUTIONP01DK043881 · NIDDK · UNIVERSITY OF WASHINGTON · PI WILLIAMS, JAMES C · 1994 to 2023
$33.5M
STONE FORMATION IN GENETIC HYPERCALCIURIAP01DK056788 · NIDDK · UNIVERSITY OF CHICAGO · PI WILLIAMS, JAMES C · 2000 to 2021
$22.5M
Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
Prevention of Renal Damage in Primary HyperoxaluriaR01DK073354 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2005 to 2008
$1.8M
NIDDK NIH HHS DK-73354NIDDK NIH HHS P01 DK043881NIDDK NIH HHS P01-DK-56788NIDDK NIH HHS U54 DK083908NIDDK NIH HHS U54-DK-083908
6 · The paper itself

Abstract

The sequence of events by which primary hyperoxaluria type 1 (PH1) causes renal failure is unclear. We hypothesize that proximal tubule (PT) is vulnerable because oxalate secretion raises calcium oxalate (CaOx) supersaturation (SS) there, leading to crystal formation and cellular injury. We studied cortical and papillary biopsies from two PH1 patients with preserved renal function, and seven native kidneys removed from four patients at the time of transplant, after short-term (2) or longer term (2) dialysis. In these patients, and another five PH1 patients without renal failure, we calculated oxalate secretion, and estimated PT CaOx SS. Plasma oxalate was elevated in all PH1 patients and inverse to creatinine clearance. Renal secretion of oxalate was present in all PH1 but rare in controls. PT CaOx SS was >1 in all nonpyridoxine-responsive PH1 before transplant and most marked in patients who developed end stage renal disease (ESRD). PT from PH1 with preserved renal function had birefringent crystals, confirming the presence of CaOx SS, but had no evidence of cortical inflammation or scarring by histopathology or hyaluronan staining. PH1 with short ESRD showed CaOx deposition and hyaluronan staining particularly at the corticomedullary junction in distal PT while cortical collecting ducts were spared. Longer ESRD showed widespread cortical CaOx, and in both groups papillary tissue had marked intratubular CaOx deposits and fibrosis. CaOx SS in PT causes CaOx crystal formation, and CaOx deposition in distal PT appears to be associated with ESRD. Minimizing PT CaOx SS may be important for preserving renal function in PH1.

Indexed as

AdolescentAdultBiopsyCalcium OxalateChild, PreschoolFemaleHumansHyperoxaluriaHyperoxaluria, PrimaryInfantKidney CalculiMaleOxalatesRenal InsufficiencyCalcium OxalateOxalatescalcium oxalateprimary hyperoxaluriaproximal tubulerenal histopathology

Identifiers

PMID24089413
PMCPMC3882369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.